We are live on ! Find out more
MCRB icon

Seres Therapeutics
MCRB

91 hedge funds and large institutions have $916M invested in Seres Therapeutics in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 6

207% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 14

20% more funds holding

Funds holding: 76 → 91 (+15)

12% more capital invested

Capital invested by funds: $820M → $916M (+$95.9M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

68% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $5.14M

Holders
91
Holders Change
+15
Holders Change %
+19.74%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
23
Increased
43
Reduced
14
Closed
6
Calls
$1.67M
Puts
$5.14M
Net Calls
-$3.48M
Net Calls Change
-$2.89M

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$27.9M
2
CCI
Columbus Circle Investors
+$10.8M
3
Jennison Associates
Jennison Associates
New York
+$7.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$6.75M
5
BFA
BlackRock Fund Advisors
California
+$6.19M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$17.4M
2
BG
BlackRock Group
United Kingdom
-$5.68M
3
BM
Bridger Management
New York
-$2.55M
4
O
OrbiMed
New York
-$2.37M
5
SM
Sabby Management
Florida
-$1.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$3.63M – – –
American Century Companies
27
American Century Companies
Missouri
$3.16M +$3.19M +5,444 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.61M +$380K +647 +17%
O
29
OrbiMed
New York
$2.5M -$2.37M -4,032 -48%
BIM
30
BlackRock Investment Management
Delaware
$1.99M +$550K +937 +38%
BA
31
BlackRock Advisors
Delaware
$1.7M -$17.4M -29,578 -91%
OM
32
Opaleye Management
Massachusetts
$1.67M +$1.69M +2,875 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.66M +$527K +899 +46%
AA
34
ALPS Advisors
Colorado
$1.61M +$1.63M +2,776 New
TCIM
35
TIAA CREF Investment Management
New York
$1.54M +$817K +1,393 +110%
IHM
36
Iguana Healthcare Management
New York
$1.45M +$1.47M +2,500 New
Charles Schwab
37
Charles Schwab
California
$1.15M +$469K +799 +68%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.09M +$564K +962 +106%
Morgan Stanley
39
Morgan Stanley
New York
$1.02M -$317K -540 -23%
OAM
40
Oxford Asset Management
United Kingdom
$1.02M +$1.03M +1,749 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$926K -$8.8K -15 -0.9%
ProShare Advisors
42
ProShare Advisors
Maryland
$918K +$48.1K +82 +5%
TA
43
Teachers Advisors
New York
$832K +$466K +795 +125%
HLA
44
Hamilton Lane Advisors
Pennsylvania
$757K +$730K +1,244 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$688K +$302K +515 +77%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$654K +$660K +1,125 New
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$606K +$103K +175 +21%
SM
48
Sabby Management
Florida
$598K -$1.43M -2,434 -70%
SAM
49
Sectoral Asset Management
Quebec, Canada
$598K +$604K +1,030 New
OPPM
50
Opus Point Partners Management
New York
$591K -$116K -198 -16%
1
2
3 4

MCRB Hedge Fund Activity: Q2 2016 in Review

91 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Seres Therapeutics (MCRB) for Q2 2016, worth a combined $916M — up 12% from $820M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MCRB positions and 6 closed out — a net gain of 17 holders — while 43 added to existing stakes and 14 trimmed.

The largest buyer was Federated Hermes, adding an estimated $27.9M. The largest seller was BlackRock Advisors, cutting an estimated $17.4M.

  • 91 institutional investors held Seres Therapeutics (MCRB) as of Q2 2016, up from 76 in Q1 2016.
  • Funds reported $916M of Seres Therapeutics stock for Q2 2016, up 12% quarter-over-quarter.
  • 23 funds opened new Seres Therapeutics positions in Q2 2016 and 6 closed out, a net change of +17 holders.
  • The largest Seres Therapeutics buyer in Q2 2016 was Federated Hermes, an estimated $27.9M added.
  • The largest Seres Therapeutics seller in Q2 2016 was BlackRock Advisors, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2016.